Structure and function of the mouse insulin-like growth factor binding protein 5 gene promoter.

The actions of insulin-like growth factors I and II (IGF-I and -II) are modulated by interactions with one or more of a family of secreted IGF binding proteins (IGFBPs). IGFBP-5, the most conserved of the six known IGFBPs, is a 252-amino-acid protein that has been shown both to potentiate and inhibit IGF action. In previous studies, we have cloned and characterized the mouse IGFBP-5 gene and demonstrated that it is expressed in a hierarchical pattern in different adult mouse tissues and during rodent embryonic development. In this report, we describe the initial analysis of the IGFBP-5 gene promoter. By transient gene transfer studies, we show the orientation-specific activity of DNA fragments containing from 31 to 4,100 bp from the 5'-flanking region of the mouse IGFBP-5 gene in directing expression of the heterologous reporter gene luciferase in Hep G2 cells. DNA fragments with only 156 bp of 5'-flanking sequence mediated over 60% of maximal promoter activity, and a segment containing the TATA box and the first 120 bp of exon 1 still conferred some promoter function. Within the highly active 156-bp region, we identified a 37-bp segment from -70 to -34 that exhibited specific binding in DNase I footprinting and gel-mobility shift experiments with Hep G2 nuclear protein extracts. The footprinted region, which is almost completely conserved in the rat and human IGFBP-5 genes, was responsible for at least 70% of the activity of the intact promoter, as evidenced by the deleterious consequences of small internal deletions within this sequence on promoter function.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  C. Larsson,et al.  Characterization of the chromosomal gene and promoter for human insulin-like growth factor binding protein-5. , 1994, The Journal of biological chemistry.

[2]  N. Copeland,et al.  Organization, expression, and chromosomal location of the mouse insulin-like growth factor binding protein 5 gene. , 1994, Genomics.

[3]  M. Rechler,et al.  Three clustered Sp1 sites are required for efficient transcription of the TATA-less promoter of the gene for insulin-like growth factor-binding protein-2 from the rat. , 1993, The Journal of biological chemistry.

[4]  P. Rotwein,et al.  A highly conserved insulin-like growth factor-binding protein (IGFBP-5) is expressed during myoblast differentiation. , 1993, The Journal of biological chemistry.

[5]  D. Andress,et al.  Carboxy-truncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells. , 1993, Biochemical and biophysical research communications.

[6]  D. Powell,et al.  Identification of an insulin-responsive element in the promoter of the human gene for insulin-like growth factor binding protein-1. , 1993, The Journal of biological chemistry.

[7]  D. Powell,et al.  Identification of a promoter element which participates in cAMP-stimulated expression of human insulin-like growth factor-binding protein-1. , 1993, The Journal of biological chemistry.

[8]  D. Clemmons,et al.  Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I , 1993, The Journal of cell biology.

[9]  D. Powell,et al.  HNF1 activates transcription of the human gene for insulin-like growth factor binding protein-1. , 1993, DNA and cell biology.

[10]  N. Ling,et al.  Structural characterization of the rat insulin-like growth factor binding protein-6 gene. , 1993, Biochemical and biophysical research communications.

[11]  N. Ling,et al.  Cloning of the rat insulin- like growth factor binding protein-5 gene and DNA sequence analysis of its promoter region. , 1993, Biochemical and biophysical research communications.

[12]  N. Ling,et al.  Structure of the rat insulin-like growth factor binding protein-4 gene. , 1993, Biochemical and biophysical research communications.

[13]  D. Andress,et al.  Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. , 1992, The Journal of biological chemistry.

[14]  D. Clemmons,et al.  Identification of the forms of insulin-like growth factor-binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. , 1992, The Journal of biological chemistry.

[15]  Silke Meyer,et al.  Compilation of vertebrate-encoded transcription factors , 1992, Nucleic Acids Res..

[16]  N. Ling,et al.  Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human. , 1991, The Journal of biological chemistry.

[17]  M. Kiefer,et al.  Molecular cloning of a new human insulin-like growth factor binding protein. , 1991, Biochemical and biophysical research communications.

[18]  D. Powell,et al.  The promoter of the human gene for insulin-like growth factor binding protein-1. Basal promoter activity in HEP G2 cells depends upon liver factor B1. , 1990, The Journal of biological chemistry.

[19]  M. Rechler,et al.  Cloning of the rat insulin-like growth factor-binding protein-2 gene and identification of a functional promoter lacking a TATA box. , 1990, Molecular endocrinology.

[20]  D. Powell,et al.  Insulin-like growth factor binding protein-3. Organization of the human chromosomal gene and demonstration of promoter activity. , 1990, The Journal of biological chemistry.

[21]  A. Brasier,et al.  Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. , 1989, BioTechniques.

[22]  M. Czech Signal transmission by the insulin-like growth factors , 1989, Cell.

[23]  P. Rotwein,et al.  Insulin-like growth factors (IGF) in muscle development. Expression of IGF-I, the IGF-I receptor, and an IGF binding protein during myoblast differentiation. , 1989, The Journal of biological chemistry.

[24]  A. Revzin Gel electrophoresis assays for DNA-protein interactions. , 1989, BioTechniques.

[25]  F. Gros,et al.  Control of myogenesis in the mouse myogenic C2 cell line by medium composition and by insulin: characterization of permissive and inducible C2 myoblasts. , 1988, Differentiation; research in biological diversity.

[26]  K. A. Lee,et al.  A small-scale procedure for preparation of nuclear extracts that support efficient transcription and pre-mRNA splicing. , 1988, Gene analysis techniques.

[27]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[28]  N. Copeland,et al.  Identification of two clusters of mouse insulin-like growth factor binding protein genes on chromosomes 1 and 11. , 1994, Genomics.

[29]  D. Clemmons,et al.  The insulin-like growth factors. , 1993, Annual review of physiology.

[30]  F. Tronche,et al.  Liver-specific expression of human insulin-like growth factor binding protein 1: functional role of transcription factor HNF1 in vivo. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Carey [8] Gel retardation , 1991 .

[32]  N. Rosenthal Identification of regulatory elements of cloned genes with functional assays. , 1987, Methods in enzymology.

[33]  M. Rechler,et al.  Insulin-like growth factor receptors. , 1985, Journal of cell science. Supplement.